Home » Topics » BioWorld Science

BioWorld Science
RSS

Suzhou Kintor and Applied Biology to evaluate proxalutamide in COVID-19 study

July 15, 2020

New activin receptor type-1 inhibitors identified at Incyte

July 15, 2020

Celgene discovers androgen receptor degradation inducers

July 15, 2020

TOLREMO therapeutics patents compounds targeting CREBBP and p300 HAT

July 15, 2020

Apolipoprotein L1 inhibitors discovered at Vertex Pharmaceuticals

July 15, 2020

Acurx Pharmaceuticals describes new bacterial DNA polymerase IIIC inhibitors

July 15, 2020

PC3X as a novel diagnostic and prognostic marker in HCC

July 15, 2020

BPI-23314 shows promising activity in xenograft models of hematological malignancies

July 15, 2020

Galectin-9 monoclonal antibody HFB9-2 displays favorable characteristics for further development

July 15, 2020

Tonix Pharmaceuticals and K-State collaborate to develop vaccine against COVID19

July 15, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...